Form 4 holding
Reporting Person's title: EVP, Chief Medical Officer
Arcutis Biotherapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 117,592
- Estimated value
- $3,174,984
- Report date
- 19 Aug 2026
- Price
- $27.00
- Ownership
- Direct